Evaluate the Effectiveness, Safety and Tolerability of Various Doses of Linezolid in Combination With Bedaquiline and Pretomanid in Adults With Pre-Extensively Drug-Resistant (Pre-XDR), Or Treatment Intolerant/Non-responsive Multidrug-Resistant (MDRTI/NR) Pulmonary Tuberculosis in India
Latest Information Update: 05 Jan 2024
Price :
$35 *
At a glance
- Drugs Bedaquiline (Primary) ; Linezolid (Primary) ; Pretomanid (Primary)
- Indications Tuberculosis
- Focus Therapeutic Use
- Acronyms mBPaL
- 28 Dec 2023 Planned End Date changed from 31 Mar 2024 to 31 Dec 2024.
- 28 Dec 2023 Planned primary completion date changed from 31 Dec 2023 to 31 Dec 2024.
- 28 Dec 2023 Status changed from recruiting to active, no longer recruiting.